Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
暂无分享,去创建一个
Jennifer R. Rider | M. Loda | P. Kantoff | M. Stampfer | E. Giovannucci | H. Sesso | M. Fiorentino | K. Penney | M. Pollak | N. Martin | Elizabeth J. Nuttall | E. Stack | R. Lis | L. Mucci | A. Pettersson | R. E. Graff | R. Flavin | S. Finn | A. Meisner | R. Graff
[1] M. Terris,et al. Obesity is associated with castration‐resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database , 2012, BJU international.
[2] Jennifer R. Rider,et al. The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[3] P. Jedlicka,et al. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs , 2011, Oncogene.
[4] G. Schwartz,et al. Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Arul M Chinnaiyan,et al. Common gene rearrangements in prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Hicks,et al. Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas , 2011, The American journal of surgical pathology.
[7] Yin Cao,et al. Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis , 2011, Cancer Prevention Research.
[8] N. Berger,et al. Energy balance, host-related factors, and cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Loda,et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Herrero-Martín,et al. The molecular pathogenesis of Ewing sarcoma , 2010, Cancer biology & therapy.
[11] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[12] M. Teitell,et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells , 2009, Proceedings of the National Academy of Sciences.
[13] Jing Ma,et al. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Sander,et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis , 2009, Nature Genetics.
[15] Pier Paolo Pandolfi,et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate , 2009, Nature Genetics.
[16] W. Hahn,et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. , 2009, Journal of the National Cancer Institute.
[17] M. Loda,et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] M. Stampfer,et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.
[19] T. Golub,et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. , 2008, Journal of the National Cancer Institute.
[20] Yan Liu,et al. Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.
[21] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[22] Adam S. Kibel,et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007 .
[23] Y Pawitan,et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.
[24] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[25] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[26] J. Hornaday,et al. Cancer Facts & Figures 2004 , 2004 .
[27] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[28] E. Rimm,et al. Validity of Self‐Reported Waist and Hip Circumferences in Men and Women , 1990, Epidemiology.
[29] C. Hennekens,et al. A randomized trial of aspirin and β-carotene among U.S. physicians , 1985 .
[30] C. Hennekens,et al. A randomized trial of aspirin and beta-carotene among U.S. physicians. , 1985, Preventive medicine.